ISRCTN38391551已完成4 期
Safety and efficacy of Sumamed® therapy in the treatment of respiratory tract infections in adults and children: international, multicentre, non-comparative study
PLIVA Hrvatska d.o.o (Croatia)0 个研究点目标入组 2,000 人开始时间: 2008年9月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Male or female out-patients, no age limits
- •2. Acute onset of disease indicated by presence of fever (>37°C)
- •3. Presence of at least 2 specific clinical signs and symptoms
- •4. Signed informed consent (for minors, parent or legal guardian written consent needs to be obtained)
排除标准
- •1. Hypersensitivity to macrolides
- •2. Treatment with any antibiotic within 14 days prior to enrolment
- •3. Participation in any clinical study within 4 weeks prior to enrolment
- •4. Prior enrolment in this study
研究者
相似试验
进行中（未招募）
不适用
Safety and Efficacy of Sumamed® Therapy in the Treatment of Respiratory Tract Infections in Adults and Children: International, Multicenter, Non-Comparative Study - SuPoRTI Studyacute pharyngitis/tonsilitisacute sinusitisacute otitis mediaacute exacerbation of chronic bronchitiscommunity acquired pneumoniaMedDRA version: 9.1Level: LLTClassification code 10001002Term: Acute pharyngitisMedDRA version: 9.1Level: LLTClassification code 10001093Term: Acute tonsillitisMedDRA version: 9.1Level: LLTClassification code 10001076Term: Acute sinusitisMedDRA version: 9.1Level: LLTClassification code 10033079Term: Otitis media acuteMedDRA version: 9.1Level: LLTClassification code 10000743Term: Acute exacerbation of chronic bronchitisMedDRA version: 9.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaEUCTR2006-006220-19-SIPLIVA Hrvatska d.o.o.2,000
进行中（未招募）
1 期
Safety and Efficacy of Sumamed® Therapy in the Treatment of Respiratory Tract Infections in Adults and Children: International, Multicenter, Non-Comparative Study - SuPoRTI Studyacute pharyngitis/tonsilitisacute sinusitisacute otitis mediaacute exacerbation of chronic bronchitiscommunity acquired pneumoniaMedDRA version: 9.1Level: LLTClassification code 10001002Term: Acute pharyngitisMedDRA version: 9.1Level: LLTClassification code 10001093Term: Acute tonsillitisMedDRA version: 9.1Level: LLTClassification code 10001076Term: Acute sinusitisMedDRA version: 9.1Level: LLTClassification code 10033079Term: Otitis media acuteMedDRA version: 9.1Level: LLTClassification code 10000743Term: Acute exacerbation of chronic bronchitisMedDRA version: 9.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaEUCTR2006-006220-19-CZPLIVA Hrvatska d.o.o.2,000
招募中
1 期
Sumatriptan and Ondansetron in Treatment of Spinal anesthesia-Induced PruritusIntrathecal fentanyl-induced pruritus.Other pruritusIRCT2017030432871N1Brain and Spinal Cord Injury Research Center75
进行中（未招募）
1 期
Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure. - sugammadex in children with renal failureSugammadex is a selective relaxant binding agent, which is administered in case of a rocuronium-induced neuromuscular block, during general anaesthesia. The aim of the trial is to investigate the use, efficacy and safety of sugammadex in children (2-17 years) with moderate to severe renal failure (creatinine clearance < 30 ml/min), compared to children with normal renal function.MedDRA version: 9.1Level: HLTClassification code 10038443Term: Renal failure and impairmentMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2008-008246-20-NLRadboud University Nijmegen Medical Center, Department of Anaesthesiology, Pain and Palliative Medic20
尚未招募
Unknown
A study on the safety and efficacy of semaglutide in obese patientsObsesity patientsJPRN-UMIN000053714Kitasato University50